CONNAUGHTON BERNADETTE sold 3.7% of their position (1.63K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $124.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/2/2026ACC: 0001159036-26-000094
Director
Since Sep 2018
-1.63K
Net shares
Net seller
$124.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1K
Price / share
$76.39
Trade value
$76.39K
% of position
2.3%
7/1/2026
43.67K→42.67K
Common Stock
Direct
Shares
−625.00
Price / share
$77.21
Trade value
$48.26K
% of position
1.5%
7/1/2026
42.67K→42.04K
Total
Net shares
−1.63K
Net value
-$124.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | S · Sale | −1K | $76.39 | $76.39K | 2.3% | 43.67K | 42.67K |
| Common Stock Direct | 7/1/2026 | S · Sale | −625.00 | $77.21 | $48.26K | 1.5% | 42.67K | 42.04K |
| Total | −1.63K | -$124.65K | ||||||
Derivative Transactions0
No derivative transactions reported